Differential expression of Yes-associated protein and phosphorylated yes-associated protein is correlated with expression of Ki-67 and phospho-ERK in colorectal adenocarcinoma

Histology and Histopathology

Volumn 28, Issue 11, 2013, Pages 1483-1490

  Kim, Dong Hoon ^a   Kim, Seok Hyung ^b   Lee, Ok Jun ^c   Huang, Song Mei ^d   Kwon, Ju Lee ^d   Kim, Jin Man ^d   Kim, Ji Yeon ^d   Seong, In Ock ^d   Song, Kyu Sang ^d   Kim, Kyung Hee ^d  

^a School of Medicine   (South Korea)

^b Sungkyunkwan University School of Medicine   (South Korea)

^c Chungbuk National University College of Medicine   (South Korea)

^d Chungnam National University   (South Korea)

Author keywords

Colorectal adenocarcinoma; Ki 67; Phosphorylated extracellular signal regulated kinase; Phosphorylated Yes associated protein; Yes associated protein

Indexed keywords

KI 67 ANTIGEN; MITOGEN ACTIVATED PROTEIN KINASE; NUCLEAR PROTEIN; TRANSCRIPTION FACTOR; TUMOR MARKER; YY1AP1 PROTEIN, HUMAN;

ADENOCARCINOMA; ARTICLE; BIOSYNTHESIS; COLORECTAL TUMOR; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; KAPLAN MEIER METHOD; MALE; METABOLISM; MIDDLE AGED; MORTALITY; PATHOLOGY; PHOSPHORYLATION; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; REAL TIME POLYMERASE CHAIN REACTION;

ADENOCARCINOMA; COLORECTAL NEOPLASMS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; KI-67 ANTIGEN; MALE; MIDDLE AGED; NUCLEAR PROTEINS; PHOSPHORYLATION; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; REAL-TIME POLYMERASE CHAIN REACTION; TRANSCRIPTION FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 84886294565     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Avruch J., Zhou D. and Bardeesy N. (2012). YAP oncogene overexpression supercharges colon cancer proliferation. Cell Cycle 11, 1090-1096.
2. Cai J., Zhang N.L., Zheng Y.G., de Wilde R.F., Maitra A. and Pan D.J. (2010). The Hippo signaling pathway restricts the oncogenic potential of an intestinal regeneration program. Genes Dev. 24, 2383-2388.
3. Chen C.H., Wang W.J., Kuo J.C., Tsai H.C., Lin J.R., Chang Z.F. and Chen R.H. (2005). Bidirectional signals transduced by DAPK-ERK interaction promote the apoptotic effect of DAPK. EMBO J. 24, 294-304.
4. Dong J., Feldmann G., Huang J., Wu S., Zhang N., Comerford S.A., Gayyed M.F., Anders R.A., Maitra A. and Pan D. (2007). Elucidation of a universal size-control mechanism in Drosophila and mammals. Cell 130, 1120-1133.
5. Hall C.A., Wang R.S., Miao J.Y., Oliva E., Shen X.Y., Wheeler T., Hilsenbeck S.G., Orsulic S. and Goode S. (2010). Hippo pathway effector Yap is an ovarian cancer oncogene. Cancer Res. 70, 8517-8525.
6. Hamilton S.R., Bosman F.T., Boffetta P., Ilyas M., Morreau H., Nakamura S.I., Quirke P., Riboli E. and Sobin L.H. (2010). WHO classification of tumours of the digestive system. 4th ed. Bosman F.T., Jaffe E.S., Lakhani S.R. and Ohgaki H. (eds). IARC. Lyon. pp 132-133.
7. Howe A.K., Aplin A.E. and Juliano R.L. (2002). Anchorage-dependent ERK signaling-mechanisms and consequences. Curr. Opin. Genet. Dev. 12, 30-35.
8. Huang J., Wu S., Barrera J., Matthews K. and Pan D. (2005). The Hippo signaling pathway coordinately regulates cell proliferation and apoptosis by inactivating Yorkie, the Drosophila homolog of YAP. Cell 122, 421-434.
9. Kang W., Tong J.H., Chan A.W., Lee T.L., Lung R.W., Leung P.P., So K.K., Wu K., Fan D., Yu J., Sung, J.J. and To K.F. (2011). Yes-associated protein 1 exhibits oncogenic property in gastric cancer and its nuclear accumulation associates with poor prognosis. Clin. Cancer Res. 17, 2130-2139.
10. Kim J.M., Kang D.W., Long L.Z., Huang S.M., Yeo M.K., Yi E.S. and Kim K.H. (2011). Differential expression of Yes-associated protein is correlated with expression of cell cycle markers and pathologic TNM staging in non-small-cell lung carcinoma. Hum. Pathol. 42, 315-323.
11. Konsavage W.M. Jr, Kyler S.L., Rennoll S.A., Jin G. and Yochum G.S. (2012). Wnt/'-catenin signaling regulates Yes-associated protein (YAP) gene expression in colorectal carcinoma cells. J. Biol. Chem. 287, 11730-11739.
12. Levidou G., Saetta A.A., Gigelou F., Karlou M., Papanastasiou P., Stamatelli A., Kavantzas N., Michalopoulos N.V., Agrogiannis G., Patsouris E. and Korkolopoulou P. (2012). ERK/pERK expression and B-raf mutations in colon adenocarcinomas: correlation with clinicopathological characteristics. World J. Surg. Oncol. 10, 47.
13. Livak K.J. and Schmittgen T.D. (2001). Analysis of relative gene expression data using real-time quantitative PCR and the 2(T)(-Delta Delta C) method. Methods 25, 402-408.
14. Muramatsu T., Imoto I., Matsui T., Kozaki K., Haruki S., Sudol M., Shimada Y., Tsuda H., Kawano T. and Inazawa J. (2011). YAP is a candidate oncogene for esophageal squamous cell carcinoma. Carcinogenesis 32, 389.
15. Pan D.J. (2010). The Hippo signaling pathway in development and cancer. Dev. Cell 19, 491-505.
16. Pearson G., Robinson F., Beers Gibson T., Xu B.E., Karandikar M., Berman K. and Cobb M.H. (2001). Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. Endocr. Rev. 22, 153-183.
17. Septer S., Edwards G., Gunewardena S., Wolfe A., Li H., Daniel J. and Apte U. (2012). Yes-associated protein is involved in proliferation and differentiation during postnatal liver development. Am. J. Physiol-Gastr. L. 302, G493-G503.
18. Sinicrope F.A., Ruan S.B., Cleary K.R., Stephens L.C., Lee J.J. and Levin B. (1995). bcl-2 and p53 oncoprotein expression during colorectal tumorigenesis. Cancer Res. 55, 237-241.
19. Steinhardt A.A., Gayyed M.F., Klein A.P., Dong J.X., Maitra A., Pan D., Montgomery E.A. and Anders R.A. (2008). Expression of Yes-associated protein in common solid tumors. Hum. Pathol. 39, 1582-1589.
20. Wang Y., Dong Q.Z., Zhang Q.F., Li Z.X., Wang E.H. and Qiu X.S. (2010). Overexpression of yes-associated protein contributes to progression and poor prognosis of non-small-cell lung cancer. Cancer Sci. 101, 1279-1285.
21. Xu M.Z., Yao T.J., Lee N.P.Y., Ng I.O.L., Chan Y.T., Zender L., Lowe S.W., Poon R.T.P. and Luk J.M. (2009). Yes-associated protein is an independent prognostic marker in hepatocellular carcinoma. Cancer 115, 4576-4585.
22. Zhao B., Li L., Tumaneng K., Wang C.Y. and Guan K.L. (2010). A coordinated phosphorylation by Lats and CK1 regulates YAP stability through SCF(beta-TRCP). Genes Dev. 24, 72-85.
23. Zhao B., Ye X., Yu J., Li L., Li W., Li S., Lin J.D., Wang C.Y., Chinnaiyan A.M., Lai Z.C. and Guan K.L. (2008). TEAD mediates YAP-dependent gene induction and growth control. Genes Dev. 22, 1962-1971.
24. Zhou D., Zhang Y., Wu H., Barry E., Yin Y., Lawrence E., Dawson D., Willis J.E., Markowitz S.D., Camargo F.D. and Avruch J. (2011). Mst1 and Mst2 protein kinases restrain intestinal stem cell proliferation and colonic tumorigenesis by inhibition of Yes-associated protein (Yap) overabundance. Proc Natl Acad Sci USA 108, E1312-1320.